Cargando…
Metformin Attenuates Inflammation and Fibrosis in Thyroid-Associated Ophthalmopathy
The pathogenesis of thyroid-associated ophthalmopathy (TAO) is still unclear, and therapeutic drugs have great limitations. As metformin has multiple therapeutic effects in many autoimmune diseases, we explored the effects of metformin on TAO in an in vitro fibroblast model. We used orbital connecti...
Autores principales: | Xu, Zhihui, Ye, Huijing, Xiao, Wei, Sun, Anqi, Yang, Shenglan, Zhang, Te, Sha, Xiaotong, Yang, Huasheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778898/ https://www.ncbi.nlm.nih.gov/pubmed/36555150 http://dx.doi.org/10.3390/ijms232415508 |
Ejemplares similares
-
Serelaxin Alleviates Fibrosis in Thyroid-Associated Ophthalmopathy via the Notch Pathway
por: Sun, Anqi, et al.
Publicado: (2023) -
Differential Circular RNA Expression Profiling of Orbital Connective Tissue From Patients With Type I and Type II Thyroid-Associated Ophthalmopathy
por: Ye, Huijing, et al.
Publicado: (2022) -
Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves’ Ophthalmopathy by Targeting Orbital Fibroblasts
por: Yang, Shenglan, et al.
Publicado: (2022) -
Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases
por: Li, Qian, et al.
Publicado: (2017) -
Disulfiram Exerts Antifibrotic and Anti-Inflammatory Therapeutic Effects on Perimysial Orbital Fibroblasts in Graves’ Orbitopathy
por: Wang, Xing, et al.
Publicado: (2022)